£0 – £10.67

Innovations in Biomarkers and Diagnostics

Event Information

Share this event

Date and Time

Location

Location

Department of Chemistry

Lensfield Road

Cambridge

CB2 1EW

United Kingdom

View Map

Friends Who Are Going
Event description

Description

The rise of personalised medicine promises tailored treatment to be delivered to the right patients at the right time. This generates parallel demand amongst scientists and clinicians alike advancing our understanding on patients’ biomarker profiles and developing rapid and accurate diagnostic tools to enable assessment of which patients will benefit from treatment in clinical practice.

Today, there are more personalised medicines than ever before in the clinical pipeline across many disease categories. As of 2015, 1 in 5 FDA approvals were for targeted therapies. Recent years have also witnessed paradigmatic developments in science and technology and streamlining of regulatory pathways and policies, all of which stimulate biomarker discovery, diagnostics development and sustainable innovation towards personalised medicine.

Join us for an evening of talks from academia and industry on innovation in biomarkers and diagnostics, followed by a panel discussion and networking session with the speakers.

Confirmed Speakers:

- Dr. Ruth March: VP & Head, Personalised Healthcare & Biomarkers, AstraZeneca

- Dr. Helen Lee: Director of Research, Department of Haematology, University of Cambridge; Founder & CEO, Diagnostics for the Real World (DRW)

- Dr. Clive Morris: Chief Medical Officer, Inivata LTD

Food and drinks are provided during the networking session.

Share with friends

Date and Time

Location

Department of Chemistry

Lensfield Road

Cambridge

CB2 1EW

United Kingdom

View Map

Save This Event

Event Saved